Official UK procurement notice
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") (NHS & healthcare)
What is being bought21 lots · detail below
Published requirement descriptionThis Framework Agreement is for the supply of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to health boards across NHS Scotland. The Goods have been split into twenty (20) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
CPV: Pharmaceutical products
How this framework works
From the published notice- Bids received
- 47 bids on the busiest of 20 lots · 45 suppliers appointed
Lots and requirements (21)Procurement structure
21 lots · all with a published value · evaluation weights differ by lotLot #1Baclofen Intrathecal InjectionsAwardedRenewal ScotlandPublished value£51,368
Supply of Baclofen Intrathecal Injections to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant.
Lot #2Oxycodone InjectionsAwardedRenewal ScotlandPublished value£573,456
The Supply of Oxycodone Injections to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant.
Lot #3Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For InjectionAwardedRenewal ScotlandPublished value£1,764,632
The Supply of Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant.
Lot #4Oxycodone Hydrochloride Prolonged Release TabletsAwardedRenewal ScotlandPublished value£380,093
The Supply of Oxycodone Hydrochloride Prolonged Release Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #5Buprenorphine PatchesAwardedRenewal ScotlandPublished value£182,163
The supply of Buprenorphine Patches to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #6Fentanyl Tablets (Sublingual)AwardedRenewal ScotlandPublished value£398,067
The Supply of Fentanyl Tablets (Sublingual) to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #7Fentanyl Sf Tablet (Buccal)CancelledRenewal UKPublished value£838
Supply of Fentanyl Sf Tablets(Buccal) to NHS Scotland in a range of presentations. The Authority has not awarded this Lot.
Lot #8Fentanyl Transdermal PatchAwardedRenewal UKPublished value£169,699
Supply of Fentanyl Transdermal Patch to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #9HydromorphoneAwardedRenewal UKPublished value£207,288
Supply of Hydromorphone Capsules and Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot to a single Framework Participant.
Lot #10Lidocaine Chlorhexidine GelAwardedRenewal UKPublished value£1,477,648
Supply of Lidocaine Chlorhexidine Gel to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #11Morphine Sulfate Modified-Release capsule (12Hr)AwardedRenewal UKPublished value£68,134
Supply of Morphine Sulfate Modified-Release capsule (12hr) to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant.
Lot #12Morphine Sulfate Modified-Release capsule (24Hr)AwardedRenewal UKPublished value£2,837
The Supply of Morphine Sulfate Modified-Release capsule (24Hr) to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant.
Lot #13Morphine Sulfate Modified-Release TabletAwardedRenewal UKPublished value£161,534
The Supply of Morphine Sulfate Modified-Release Tablet to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #14Oxycodone Hydrochloride CapsulesAwardedRenewal UKPublished value£139,732
The Supply of Oxycodone Hydrochloride Capsules to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #15Propofol InjectionAwardedRenewal UKPublished value£1,849,832
The Supply of Propofol Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #16Tramadol Hydrochloride Modified Release TabletsAwardedRenewal UKPublished value£11,917
The Supply of Tramadol Hydrochloride Modified Release Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #17Oxycodone Oral SolutionAwardedRenewal UKPublished value£439,902
The Supply of Oxycodone Oral Solution to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #18Levobupivacaine (As Hydrochloride) Solution For InfusionAwardedRenewal ScotlandPublished value£1,353,792
The Supply of Levobupivacaine (As Hydrochloride) Solution For Infusion to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Lot #19Supply to NHSS Pharmaceuticals "Specials" ServiceAwardedRenewal ScotlandPublished value£1,472,680
The supply of a range of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to the NHSS Pharmaceuticals "Specials" Service. The Authority has awarded each product line within this Lot to a single Framework Participant.
Lot #20Levobupivacaine Solution for injection ampoules (unwrapped)AwardedRenewal UKPublished value£40
Supply of Levobupivacaine solution for injection ampoules (unwrapped) all other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines in a range of presentations. The Authority has awarded each product line within this Lot to a single Framework Participant.
Lot #21All other Analgesics and Anaesthetic Generic MedicinesAwardedRenewal ScotlandPublished value£42,293,984
Supply of all other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines in a range of presentations. The Authority has awarded each product line within this Lot to a single Framework Participant.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Lots publish different evaluation splits; there is no single procedure weighting.
9 more lots publish their own split on the notice.
- Suitability
Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
- Technical & professional ability
(a)Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of start of the tender.
(b)Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
(c)All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.
(d)Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.
(e)Potential Framework Participants must be able to demonstrate that all devices tendered and associated ancillaries under this Framework Agreement comply with Medical Devices Regulations 2002 (SI 2002 No 618, as amended) (UK MDR 2002) and have an appropriate declaration of conformity and display a valid CE, CE UKNI or UKCA mark for Ethyl Chloride Spray and Lidocaine Gel
Minimum: (a)Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of the start of the tender should be included in the Qualification Envelope of the ITT under the Techni…
- Price carries 80–95 points depending on the lot; most lots put it at 95 points.
- “NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease…” is a framework: the contest is a place on its panel, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 6 Aug 2025, 11:06 BST
- Last source update
- 6 Jan 2026, 13:39 GMT
- Award evaluation window
- 8 Sept 2025 – …
- FTS notice number
2026/S 000-000677- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-058241Find a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.
Publisher note: The estimated values referred to in Section II.1.5 and all Lots covers the twenty-four (24) months framework duration and the twelve (12) month extension period of the framework agreement. (SC Ref:818056)
How it was run
Official notice- Appointment period ends
- 8 Sept 2025, 12:00 BST
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bid validity
- 90 days from the deadline
- Bids opened
- 8 Sept 2025, 12:00 BST
Timeline
8 Sept 2025 → 6 Jan 2026 · 3 dates- Admission / appointment period endsperiod end, not a bid countdown8 Sept 2025, 12:00 BST
- Bids opened8 Sept 2025, 12:00 BST
- Notice published289 days ago6 Jan 2026, 13:39 GMT
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete6 Jan 2026, 13:39 GMT
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast20 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Lot 1 - Baclofen Intrathecal Injections
- Signed
- 12 Dec 2025
- Value
- £26,445
- Status
- active
Lot 8 - Fentanyl Transdermal Patch
- Signed
- 12 Dec 2025
- Value
- £83,511
- Status
- active
Lot 9 - Hydromorphone
- Signed
- 12 Dec 2025
- Value
- £25,482
- Status
- active
Lot 13 - Morphine Sulfate Modified-Release Tablet
- Signed
- 12 Dec 2025
- Value
- £96,453
- Status
- active
Lot 14 - Oxycodone Hydrochloride Capsules
- Signed
- 12 Dec 2025
- Value
- £81,939
- Status
- active
Lot 15 - Propofol Injection
- Signed
- 12 Dec 2025
- Value
- £1,593,081
- Status
- active
Lot 16 - Tramadol Hydrochloride Modified Release Tablets
- Signed
- 12 Dec 2025
- Value
- £10,521
- Status
- active
Lot 17 - Oxycodone Oral Solution
- Signed
- 12 Dec 2025
- Value
- £260,523
- Status
- active
Lot 18 - Levobupivacaine (As Hydrochloride) Solution For Infusion
- Signed
- 12 Dec 2025
- Value
- £881,598
- Status
- active
Lot 19 - Supply to NHSS Pharmaceuticals "Specials" Service
- Signed
- 12 Dec 2025
- Value
- £576,948
- Status
- active
Lot 11 - Morphine Sulfate Modified-Release capsule (12Hr)
- Signed
- 12 Dec 2025
- Value
- £53,472
- Status
- active
Lot 20 - Levobupivacaine Solution for injection ampoules (unwrapped)
- Signed
- 12 Dec 2025
- Value
- £30
- Status
- active
Lot 21 - All other Analgesics and Anaesthetic Generic Medicines
- Signed
- 12 Dec 2025
- Value
- £15,957,588
- Status
- active
Lot 10 - Lidocaine Chlorhexidine Gel
- Signed
- 12 Dec 2025
- Value
- £952,578
- Status
- active
Lot 12 - Morphine Sulfate Modified-Release capsule (24Hr)
- Signed
- 12 Dec 2025
- Value
- £3,414
- Status
- active
Lot 2 - Oxycodone Injections
- Signed
- 12 Dec 2025
- Value
- £333,954
- Status
- active
Lot 3 - Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection
- Signed
- 12 Dec 2025
- Value
- £1,090,530
- Status
- active
Lot 4 - Oxycodone Hydrochloride Prolonged Release Tablets
- Signed
- 12 Dec 2025
- Value
- £185,631
- Status
- active
Lot 5 - Buprenorphine Patches
- Signed
- 12 Dec 2025
- Value
- £51,042
- Status
- active
Lot 6 - Fentanyl Tablets (Sublingual)
- Signed
- 12 Dec 2025
- Value
- £206,583
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · Baclofen Intrathecal Injections | 1bids · 1 electronic · 1 from abroad | 1 | — | — |
| 2 · Oxycodone Injections | 1bids · 1 electronic · 1 from abroad | 1 | — | — |
| 3 · Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection | 1bids · 1 electronic · 1 from abroad | 1 | — | — |
| 4 · Oxycodone Hydrochloride Prolonged Release Tablets | 7bids · 7 electronic · 7 from abroad | 7 | — | — |
| 5 · Buprenorphine Patches | 5bids · 5 electronic · 5 from abroad | 5 | — | — |
| 6 · Fentanyl Tablets (Sublingual) | 2bids · 2 electronic · 2 from abroad | 2 | — | — |
| 8 · Fentanyl Transdermal Patch | 3bids · 3 electronic · 3 from abroad | 3 | — | — |
| 9 · Hydromorphone | 1bids · 1 electronic · 1 from abroad | 1 | — | — |
| 10 · Lidocaine Chlorhexidine Gel | 2bids · 2 electronic · 2 from abroad | 2 | — | — |
| 11 · Morphine Sulfate Modified-Release capsule (12Hr) | 1bids · 1 electronic · 1 from abroad | 1 | — | — |
| 12 · Morphine Sulfate Modified-Release capsule (24Hr) | 1bids · 1 electronic · 1 from abroad | 1 | — | — |
| 13 · Morphine Sulfate Modified-Release Tablet | 2bids · 2 electronic · 2 from abroad | 2 | — | — |
| 14 · Oxycodone Hydrochloride Capsules | 4bids · 4 electronic · 4 from abroad | 4 | — | — |
| 15 · Propofol Injection | 3bids · 3 electronic · 3 from abroad | 3 | — | — |
| 16 · Tramadol Hydrochloride Modified Release Tablets | 4bids · 4 electronic · 4 from abroad | 4 | — | — |
| 17 · Oxycodone Oral Solution | 4bids · 4 electronic · 4 from abroad | 4 | — | — |
| 18 · Levobupivacaine (As Hydrochloride) Solution For Infusion | 2bids · 2 electronic · 2 from abroad | 2 | — | — |
| 19 · Supply to NHSS Pharmaceuticals "Specials" Service | 6bids · 6 electronic · 6 from abroad | 6 | — | — |
| 20 · Levobupivacaine Solution for injection ampoules (unwrapped) | 1bids · 0 electronic · 1 from abroad | 1 | — | — |
| 21 · All other Analgesics and Anaesthetic Generic Medicines | 47bids · 47 electronic · 47 from abroad | 47 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Edinburgh Sheriff CourtReview body
Framework contractors & participating bidders
45 commercial parties on the notice- Accord Healthcare LtdFramework contractor
- Accord-UK LtdFramework contractor
- Aguettant LtdFramework contractor
- Arcadia Pharma Limited T/A Arcadia MedicalFramework contractor
- Aspen Healthcare SolutionsFramework contractor
- Aspire Pharma LtdFramework contractor
- B Braun Medical LtdFramework contractor
- Baxter Healthcare LtdFramework contractor
- Bowmed Ibisqus LimitedFramework contractor
- Chiesi LimitedFramework contractor
Show 35 more suppliers
- Clinimed LimitedFramework contractor
- DRUGSRUS LTDFramework contractor
- Ennogen Healthcare International LtdFramework contractor
- Fresenius Kabi LimitedFramework contractor
- Gerot Lannach UK LtdFramework contractor
- GlaxoSmithKlineFramework contractor
- Glenmark Pharmaceuticals Europe LtdFramework contractor
- Hikma PharmaceuticalsFramework contractor
- Intrapharm Laboratories LtdFramework contractor
- Kent Pharmaceuticals LtdFramework contractor
- Kyowa Kirin International NewCo LtdFramework contractor
- Martindale PharmaFramework contractor
- Medreich PLCFramework contractor
- Mercury Pharmaceuticals LimitedFramework contractor
- Morningside Pharmaceuticals LimitedFramework contractor
- Napp Pharmaceuticals LimitedFramework contractor
- Neon HealthcareFramework contractor
- Novumgen LimitedFramework contractor
- Optimum MedicalFramework contractor
- Panpharma UK LtdFramework contractor
- Pfizer LtdFramework contractor
- Phoenix LabsFramework contractor
- Piramal Critical Care LtdFramework contractor
- Qdem Pharmaceuticals LimitedFramework contractor
- Ridge Pharma LimitedFramework contractor
- STADA UK - Thornton & RossFramework contractor
- SVP Pharma LtdFramework contractor
- SandozFramework contractor
- Teva UK LtdFramework contractor
- Torbay PharmaFramework contractor
- Typharm LtdFramework contractor
- Viatris UK Healthcare LtdFramework contractor
- Wockhardt UK LimitedFramework contractor
- Zentiva UKFramework contractor
- hameln pharma ltdFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.